Crossmark

Regional variability in therapeutic hypothermia eligibility criteria for neonatal hypoxic-ischemic encephalopathy

Published Online: 2024-04-22

Published Print: 2024-10

Authors

Proietti, Jacopo

Boylan, Geraldine B.

Walsh, Brian H. http://orcid.org/0000-0003-4665-6884
License Information

Text and Data Mining valid from 2024-04-22

Version of Record valid from 2024-04-22
More Information

Article History

Received: 31 December 2023

Revised: 13 March 2024

Accepted: 24 March 2024

First Online: 22 April 2024

Competing interests

: G.B.B. is founder and shareholder in Kephala Ltd and Cergenx ltd; has received consulting fees and/or honoraria from GW Pharmaceuticals, Nihon Kohden and UCB Pharma. J.P. and B.H.W. have no conflicts of interest.

Document is current